Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2011 Feb;13(1):88-94.
doi: 10.1007/s11883-010-0146-z.

Lipid effects of endocrine medications

Dan V Mihailescu  1 , Avni Vora, Theodore Mazzone
Affiliations
Review

Lipid effects of endocrine medications

Dan V Mihailescu et al. Curr Atheroscler Rep. 2011 Feb.

Abstract

Various alterations of lipid homeostasis have a significant role in the pathophysiology of the artherosclerotic process. The effects of usual lipid-lowering agents such as statins, fibrates, or niacin are well known, but other endocrine therapeutic agents could also affect the blood levels of various lipoproteins and, in turn, influence atheroma formation. In this review, we attempt to summarize the effect of several hormonal and non-hormonal endocrine agents on lipid metabolism, including insulin, thyroid hormone, sex hormones, glucocorticoids, growth hormone, and several anti-diabetic agents.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. JAMA. 1989 Feb 24;261(8):1165-8 - PubMed
    1. Eur J Cardiovasc Prev Rehabil. 2011 Feb;18(1):86-96 - PubMed
    1. JAMA. 2002 Jul 17;288(3):321-33 - PubMed
    1. J Intern Med. 2004 Jul;256(1):1-14 - PubMed
    1. BJOG. 2002 Sep;109(9):1056-62 - PubMed

MeSH terms

LinkOut - more resources